Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Gold nanoparticles in breast cancer treatment: promise and potential pitfalls.

Lee J, Chatterjee DK, Lee MH, Krishnan S.

Cancer Lett. 2014 May 28;347(1):46-53. doi: 10.1016/j.canlet.2014.02.006. Epub 2014 Feb 17. Review.

2.

Convergence of nanotechnology with radiation therapy-insights and implications for clinical translation.

Chatterjee DK, Wolfe T, Lee J, Brown AP, Singh PK, Bhattarai SR, Diagaradjane P, Krishnan S.

Transl Cancer Res. 2013 Aug 23;2(4):256-268.

3.

Nanoparticle-mediated hyperthermia in cancer therapy.

Chatterjee DK, Diagaradjane P, Krishnan S.

Ther Deliv. 2011 Aug;2(8):1001-14.

4.

Recombinant protein quality evaluation: proposal for a minimal information standard.

Buckle AM, Bate MA, Androulakis S, Cinquanta M, Basquin J, Bonneau F, Chatterjee DK, Cittaro D, Gräslund S, Gruszka A, Page R, Suppmann S, Wheeler JX, Agostini D, Taussig M, Taylor CF, Bottomley SP, Villaverde A, de Marco A.

Stand Genomic Sci. 2011 Nov 30;5(2):195-7. doi: 10.4056/sigs.1834511. Epub 2011 Nov 22. No abstract available.

5.

Protein delivery using engineered virus-like particles.

Kaczmarczyk SJ, Sitaraman K, Young HA, Hughes SH, Chatterjee DK.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):16998-7003. doi: 10.1073/pnas.1101874108. Epub 2011 Sep 26.

6.

Optimization of a cyclic peptide inhibitor of Ser/Thr phosphatase PPM1D (Wip1).

Hayashi R, Tanoue K, Durell SR, Chatterjee DK, Jenkins LM, Appella DH, Appella E.

Biochemistry. 2011 May 31;50(21):4537-49. doi: 10.1021/bi101949t. Epub 2011 May 9.

7.

Protein-protein interactions: an application of Tus-Ter mediated protein microarray system.

Sitaraman K, Chatterjee DK.

Methods Mol Biol. 2011;723:185-200. doi: 10.1007/978-1-61779-043-0_12.

PMID:
21370066
8.

Small upconverting fluorescent nanoparticles for biomedical applications.

Chatterjee DK, Gnanasammandhan MK, Zhang Y.

Small. 2010 Dec 20;6(24):2781-95. doi: 10.1002/smll.201000418. Review.

PMID:
21064086
9.

Tus, an E. coli protein, contains mammalian nuclear targeting and exporting signals.

Kaczmarczyk SJ, Sitaraman K, Hill T, Hartley JL, Chatterjee DK.

PLoS One. 2010 Jan 26;5(1):e8889. doi: 10.1371/journal.pone.0008889.

10.

High-throughput protein expression using cell-free system.

Sitaraman K, Chatterjee DK.

Methods Mol Biol. 2009;498:229-44. doi: 10.1007/978-1-59745-196-3_15.

PMID:
18988029
11.

Nanoparticles in photodynamic therapy: an emerging paradigm.

Chatterjee DK, Fong LS, Zhang Y.

Adv Drug Deliv Rev. 2008 Dec 14;60(15):1627-37. doi: 10.1016/j.addr.2008.08.003. Epub 2008 Sep 20. Review.

PMID:
18930086
12.

Protein microarray on-demand: a novel protein microarray system.

Chatterjee DK, Sitaraman K, Baptista C, Hartley J, Hill TM, Munroe DJ.

PLoS One. 2008 Sep 24;3(9):e3265. doi: 10.1371/journal.pone.0003265.

13.

Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells.

Chatterjee DK, Yong Z.

Nanomedicine (Lond). 2008 Feb;3(1):73-82. doi: 10.2217/17435889.3.1.73.

PMID:
18393642
14.

Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals.

Chatterjee DK, Rufaihah AJ, Zhang Y.

Biomaterials. 2008 Mar;29(7):937-43. Epub 2007 Dec 3.

PMID:
18061257
15.

The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases.

Yamaguchi H, Durell SR, Chatterjee DK, Anderson CW, Appella E.

Biochemistry. 2007 Nov 6;46(44):12594-603. Epub 2007 Oct 16.

PMID:
17939684
16.

Investigating the "steric gate" of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by targeted insertion of unnatural amino acids.

Klarmann GJ, Eisenhauer BM, Zhang Y, Gotte M, Pata JD, Chatterjee DK, Hecht SM, Le Grice SF.

Biochemistry. 2007 Feb 27;46(8):2118-26. Epub 2007 Feb 3.

PMID:
17274599
17.

Enhancement of soluble protein expression through the use of fusion tags.

Esposito D, Chatterjee DK.

Curr Opin Biotechnol. 2006 Aug;17(4):353-8. Epub 2006 Jun 15. Review.

PMID:
16781139
18.

Enhanced soluble protein expression using two new fusion tags.

Chatterjee DK, Esposito D.

Protein Expr Purif. 2006 Mar;46(1):122-9. Epub 2005 Aug 24.

PMID:
16146696
19.

Substrate specificity of the human protein phosphatase 2Cdelta, Wip1.

Yamaguchi H, Minopoli G, Demidov ON, Chatterjee DK, Anderson CW, Durell SR, Appella E.

Biochemistry. 2005 Apr 12;44(14):5285-94.

PMID:
15807522
20.

Site- and subunit-specific incorporation of unnatural amino acids into HIV-1 reverse transcriptase.

Klarmann GJ, Eisenhauer BM, Zhang Y, Sitaraman K, Chatterjee DK, Hecht SM, Le Grice SF.

Protein Expr Purif. 2004 Nov;38(1):37-44.

PMID:
15477080
21.

A novel cell-free protein synthesis system.

Sitaraman K, Esposito D, Klarmann G, Le Grice SF, Hartley JL, Chatterjee DK.

J Biotechnol. 2004 Jun 10;110(3):257-63.

PMID:
15163516
22.

Semisynthetic modifications of hemiaminal function at ornithine unit of mulundocandin, towards chemical stability and antifungal activity.

Lal B, Gund VG, Gangopadhyay AK, Nadkarni SR, Dikshit V, Chatterjee DK, Shirvaikar R.

Bioorg Med Chem. 2003 Nov 17;11(23):5189-98.

PMID:
14604682
23.
24.

The role of template-primer in protection of reverse transcriptase from thermal inactivation.

Gerard GF, Potter RJ, Smith MD, Rosenthal K, Dhariwal G, Lee J, Chatterjee DK.

Nucleic Acids Res. 2002 Jul 15;30(14):3118-29.

25.

Comparative chemotherapeutic efficacy of balhimycin, desgluco-balhimycin against experimental MSSA and MRSA infection in mice.

Chatterjee DK, Sarma P, Jani RH, Klesel N, Isert D.

Indian J Exp Biol. 2000 Jul;38(7):681-6.

PMID:
11215311
26.

Comparative pathogenicity of trichomonas vaginalis isolated from symptomatic & asymptomatic cases.

Bhatt R, Deodhar L, Pandit D, Bhise R, Chatterjee DK.

J Postgrad Med. 1997 Jul-Sep;43(3):68-70.

27.
28.

Antimalarial activity of novel ring-contracted artemisinin derivatives.

Venugopalan B, Bapat CP, Karnik PJ, Chatterjee DK, Iyer N, Lepcha D.

J Med Chem. 1995 May 26;38(11):1922-7.

PMID:
7783124
29.

Comparative pathogenicity of Trichomonas vaginalis isolated from symptomatic and asymptomatic cases.

Bhatt R, Pandit D, Deodhar L, Bhise R, Chatterjee DK.

J Postgrad Med. 1993 Oct-Dec;39(4):187-9.

30.

Cloning and characterization of genes for the PvuI restriction and modification system.

Smith MD, Longo M, Gerard GF, Chatterjee DK.

Nucleic Acids Res. 1992 Nov 11;20(21):5743-7.

31.

Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity.

Chatterjee S, Chatterjee DK, Jani RH, Blumbach J, Ganguli BN, Klesel N, Limbert M, Seibert G.

J Antibiot (Tokyo). 1992 Jun;45(6):839-45.

32.

Genetic organization of the KpnI restriction--modification system.

Chatterjee DK, Hammond AW, Blakesley RW, Adams SM, Gerard GF.

Nucleic Acids Res. 1991 Dec 11;19(23):6505-9.

33.

Cloning the KpnI restriction-modification system in Escherichia coli.

Hammond AW, Gerard GF, Chatterjee DK.

Gene. 1991 Jan 2;97(1):97-102.

PMID:
1995432
34.

Cloning and overexpression of the gene encoding bacteriophage T5 DNA polymerase.

Chatterjee DK, Fujimura RK, Campbell JH, Gerard GF.

Gene. 1991 Jan 2;97(1):13-9.

PMID:
1995424
35.

Characterization of NgoAIII, an isoschizomer of SstII from a strain of Neisseria gonorrhoea.

Hammond AW, Gerard GF, Chatterjee DK.

Nucleic Acids Res. 1989 Aug 25;17(16):6750. No abstract available.

36.

Characterization of a restriction enzyme from a strain of Neisseria gonorrhoea which recognizes 5'G/CCGGC3', an isoschizomer of NaeI.

Hammond AW, Gerard GF, Campbell JH, Chatterjee DK.

Nucleic Acids Res. 1989 Apr 25;17(8):3320. No abstract available.

37.

Enrichment for 5'-TG termini: a method for subcloning structural genes into expression vectors.

D'Alessio JM, Hammond AW, Chatterjee DK.

Gene. 1988 Nov 15;71(1):49-56.

PMID:
3063614
38.

Expression of degradative genes of Pseudomonas putida in Caulobacter crescentus.

Chatterjee DK, Chatterjee P.

J Bacteriol. 1987 Jul;169(7):2962-6.

39.

Metabolism of aromatic compounds by Caulobacter crescentus.

Chatterjee DK, Bourquin AW.

J Bacteriol. 1987 May;169(5):1993-6.

40.

Nucleotide sequence and expression of clcD, a plasmid-borne dienelactone hydrolase gene from Pseudomonas sp. strain B13.

Frantz B, Ngai KL, Chatterjee DK, Ornston LN, Chakrabarty AM.

J Bacteriol. 1987 Feb;169(2):704-9.

41.

A set of cassettes and improved vectors for genetic and biochemical characterization of Pseudomonas genes.

Deretic V, Chandrasekharappa S, Gill JF, Chatterjee DK, Chakrabarty AM.

Gene. 1987;57(1):61-72.

PMID:
3123327
42.

Antiamoebic activity of chonemorphine, a steroidal alkaloid, in experimental models.

Chatterjee DK, Iyer N, Ganguli BN.

Parasitol Res. 1987;74(1):30-3.

PMID:
2894025
43.

Microbial degradation of halogenated compounds.

Ghosal D, You IS, Chatterjee DK, Chakrabarty AM.

Science. 1985 Apr 12;228(4696):135-42.

PMID:
17779620
44.

Genes specifying degradation of 3-chlorobenzoic acid in plasmids pAC27 and pJP4.

Ghosal D, You IS, Chatterjee DK, Chakrabarty AM.

Proc Natl Acad Sci U S A. 1985 Mar;82(6):1638-42.

45.

Plasmids in the degradation of chlorinated aromatic compounds.

Ghosal D, You IS, Chatterjee DK, Chakrabarty AM.

Basic Life Sci. 1985;30:667-86. No abstract available.

PMID:
2990433
46.
47.

Microbial biodegradation of 2,4,5-trichlorophenoxyacetic acid and chlorophenols.

Karns JS, Kilbane JJ, Chatterjee DK, Chakrabarty AM.

Basic Life Sci. 1984;28:3-21.

PMID:
6704076
48.

Caerulomycin, an antifungal antibiotic with marked in vitro and in vivo activity against Entamoeba histolytica.

Chatterjee DK, Raether W, Iyer N, Ganguli BN.

Z Parasitenkd. 1984;70(5):569-73.

PMID:
6095553
49.
50.

Detoxification of 2,4,5-trichlorophenoxyacetic acid from contaminated soil by Pseudomonas cepacia.

Kilbane JJ, Chatterjee DK, Chakrabarty AM.

Appl Environ Microbiol. 1983 May;45(5):1697-700.

Supplemental Content

Loading ...
Support Center